The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 101-59-87
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2024
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Marchenko N.R.

Research Institute of Eye Diseases

Kasparova E.A.

Krasnov Research Institute of Eye Diseases

Budnikova E.A.

Research Institute of Eye Diseases

Makarova M.A.

Krasnov Research Institute of Eye Diseases

Anterior eye segment damage in coronavirus infection (COVID-19)

Authors:

Marchenko N.R., Kasparova E.A., Budnikova E.A., Makarova M.A.

More about the authors

Journal: Russian Annals of Ophthalmology. 2021;137(6): 142‑148

DOI: 10.17116/oftalma2021137061142

Views: 7168

Downloaded: 244

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Marchenko NR, Kasparova EA, Budnikova EA, Makarova MA. Anterior eye segment damage in coronavirus infection (COVID-19). Russian Annals of Ophthalmology. 2021;137(6):142‑148. (In Russ.)
https://doi.org/10.17116/oftalma2021137061142

Подписка 2025 (Russian Annals of Ophthalmology)
 
МСФ на ЯМ
Close metadata
Recommended articles:
SARS-CoV-2-induced non-bacterial endo­myocarditis with the deve­lopment of acquired heart defe­cts. Russian Journal of Archive of Pathology. 2023;(6):52-61
Alopecia and COVID-19: possible etiopathogenetic variants and therapeutic approach. Problems of Balneology, Physiotherapy and Exercise Therapy. 2023;(5):56-63
Medi­cal reha­bilitation features of patients suffered from new coro­navirus infe­ction. Problems of Balneology, Physiotherapy and Exercise Therapy. 2023;(5):64-69
New coro­navirus infe­ction in the II trimester of pregnancy: peri­natal and mate­rnal consequences. Russian Bulletin of Obstetrician-Gynecologist. 2023;(6):34-41
Type 2 diabetes mellitus and COVID-19: lethality predictors. Russian Journal of Preventive Medi­cine. 2023;(11):53-56
Symptoms in the SARS-CoV-2 survivors with critical lung damage (CT-4). Russian Journal of Preventive Medi­cine. 2023;(11):69-77
Left ventricular thro­mbosis and acute heart failure in patients after SARS-CoV-2 infe­ction. Russian Journal of Preventive Medi­cine. 2023;(11):78-81
Clinical, instrumental and labo­ratory data on consequences of COVID-19 in delayed period after admi­ssion. Russian Cardiology Bulletin. 2023;(4):56-66
Asse­ssment of labo­ratory para­meters at various COVID-19 phases in patients with gastrointestinal symptoms. Russian Journal of Evidence-Based Gastroenterology. 2023;(4):89-94
Prospects for predicting preterm labor. Russian Bulletin of Obstetrician-Gynecologist. 2023;(6-2):127-134

Conjunctivitis may appear as the first symptom of the coronavirus infection (COVID-19). In isolated cases, the lesion of the conjunctiva evokes a systemic infectious process. Currently, the conjunctiva is not considered as an area of long-term reproduction of coronavirus, and its damage is caused by hyperproduction of pro-inflammatory cytokines (especially IL-6); development of iridocyclitis and keratoconjunctivitis is also possible. Most often, local corticosteroids are used to treat these processes, although their use requires caution due to the risk of activating secondary infection (herpetic bacterial, fungal), which often develops as a result of immunodeficiency caused both by COVID-19 and the massive corticosteroid and antibiotic therapy employed when the course of the disease is severe. The severe condition of patients, the lung ventilation, and the prone position all contribute to corneal erosions, exposure keratopathy, pseudomonas aeruginosa keratitis and angle-closure glaucoma attacks. The risk of transmission of coronavirus infection during keratoplasty is estimated as minimal.

Keywords:

COVID-19
SARS-CoV-2
conjunctivitis
keratoconjunctivitis
iridocyclitis
keratoplasty
ocular complications
prone position

Authors:

Marchenko N.R.

Research Institute of Eye Diseases

Kasparova E.A.

Krasnov Research Institute of Eye Diseases

Budnikova E.A.

Research Institute of Eye Diseases

Makarova M.A.

Krasnov Research Institute of Eye Diseases

Received:

15.07.2021

Accepted:

24.10.2021

List of references:

  1. World Health Organization (WHO). Summary table of SARS cases by country. 1 Nov. 2002 — 7 Aug. 2003. Summary Table of SARS Cases by Country N-A. Geneva (Switzerland): World Health Organisation (WHO). 2003. Accessed Jun 14, 2021. https://www.who.int/csr/sars/country/2003_08_15/en/
  2. Killerby ME, Biggs HM, Midgley CM, Gerber SI, Watson JT. Middle East Respiratory Syndrome Coronavirus Transmission. Emerg Infect Dis. 2020; 26(2):191-198.  https://doi.org/10.3201/eid2602.190697
  3. World Health Organization (WHO). Coronavirus disease 2019 (COVID-19) Situation Report — 51, 11 March 2020. World Health Organization. 2020. Accessed Jun 14, 2021. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf
  4. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W; China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8): 727-733.  https://doi.org/10.1056/NEJMoa2001017
  5. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.  https://doi.org/10.1016/S0140-6736(20)30183-5
  6. American Academy of Ophthalmology. Alert: important coronavirus updates for ophthalmologists. Accessed Jun 14, 2021. https://www.aao.org/headline/alert-important-coronavirus-context
  7. Seah I, Agrawal R. Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals. Ocul Immunol Inflamm. 2020;28(3):391-395.  https://doi.org/10.1080/09273948.2020.1738501
  8. Bhattacharyya A, Sarma P, Sarma B, Kumar S, Gogoi T, Kaur H, Prajapat M. Bacteriological pattern and their correlation with complications in culture positive cases of acute bacterial conjunctivitis in a tertiary care hospital of upper Assam: A cross sectional study. Medicine (Baltimore). 2020;99(7):1-10.  https://doi.org/10.1097/MD.0000000000018570
  9. Ho D, Low R, Tong L, Gupta V, Veeraraghavan A, Agrawal R. COVID-19 and the Ocular Surface: A Review of Transmission and Manifestations. Ocul Immunol Inflamm. 2020;28(5):726-734.  https://doi.org/10.1080/09273948.2020
  10. Sarma P, Kaur H, Kaur H, Bhattacharyya J, Prajapat M, Shekhar N, Avti P, Kumar S, Medhi MB, Das D, Bhattacharyya A, Prakash PA. Ocular manifestations and tear or conjunctival swab PCR positivity for 2019-nCoV in patients with COVID-19: A systematic review and meta-analysis (3/30/2020). Lancet. 2020. https://doi.org/10.2139/ssrn.3566161
  11. World Health Organization. Origin of SARS-CoV-2, 26 March 2020. World Health Organization. 2020. Accessed Jun 14, 2021. https://extranet.who.int/iris/restricted/bitstream/handle/10665/332197/WHO-2019-nCoVFAQ-Virus_origin-2020.1-eng.pdf
  12. Chan JF, Kok KH, Zhu Z, Chu H, To KK, Yuan S, Yuen KY. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9(1):221-236.  https://doi.org/10.1080/22221751.2020.1719902
  13. Savaskan E, Löffler KU, Meier F, Müller-Spahn F, Flammer J, Meyer P. Immunohistochemical localization of angiotensin-converting enzyme, angiotensin II and AT1 receptor in human ocular tissues. Ophthalmic Res. 2004;36(6):312-320.  https://doi.org/10.1159/000081633
  14. Holappa M, Valjakka J, Vaajanen A. Angiotensin (1-7) and ACE2, «the hot spots» of renin-angiotensin system, detected in the human aqueous humor. Open Ophthalmol J. 2015;9:28-32.  https://doi.org/10.2174/1874364101509010028
  15. Määttä M, Tervahartiala T, Kaarniranta K, Tang Y, Yan L, Tuukkanen J, Sorsa T. Immunolocalization of EMMPRIN (CD147) in the human eye and detection of soluble form of EMMPRIN in ocular fluids. Curr Eye Res. 2006;31(11):917-924.  https://doi.org/10.1080/02713680600932290
  16. Nguyen TT, Sathe S, Stallone M. Expression of CD147 and Cyclophilin A in dry eye disease. Invest Ophthalmol Vis Sci. 2016;57(12):411. 
  17. Sungnak W, Huang N, Bécavin C, Berg M, Queen R, Litvinukova M, Talavera-López C, Maatz H, Reichart D, Sampaziotis F, Worlock KB, Yoshida M, Barnes JL; HCA Lung Biological Network. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26(5):681-687.  https://doi.org/10.1038/s41591-020-0868-6
  18. Xiang M, Zhang W, Wen H, Mo L, Zhao Y, Zhan Y. Comparative transcriptome analysis of human conjunctiva between normal and conjunctivochalasis persons by RNA sequencing. Exp Eye Res. 2019;184:38-47.  https://doi.org/10.1016/j.exer.2019.04.005
  19. Nora RLD, Putera I, Khalisha DF, Septiana I, Ridwan AS, Sitompul R. Are eyes the windows to COVID-19? Systematic review and meta-analysis. BMJ Open Ophthalmol. 2020;5:e000563. https://doi.org/10.1136/bmjophth-2020-000563
  20. Chen L, Deng C, Chen X, Zhang X, Chen B, Yu H, Qin Y, Xiao K, Zhang H, Sun X. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study. Acta Ophthalmol. 2020;98(8):951-959.  https://doi.org/10.1111/aos.14472
  21. Loffredo L, Pacella F, Pacella E, Tiscione G, Oliva A, Violi F. Conjunctivitis and COVID-19: A meta-analysis. J Med Virol. 2020;92(9):1413-1414. https://doi.org/10.1002/jmv.25938
  22. Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L, Wu K. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in hubei province, China. JAMA Ophthalmol. 2020;138(5):575-578.  https://doi.org/10.1001/jamaophthalmol.2020.1291
  23. Hong N, Yu W, Xia J, Shen Y, Yap M, Han W. Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19. Acta Ophthalmol. 2020;10.1111/aos.14445. https://doi.org/10.1111/aos.14445
  24. Karimi S, Arabi A, Shahraki T, Safi S. Detection of severe acute respiratory syndrome Coronavirus-2 in the tears of patients with Coronavirus disease 2019. Eye (Lond). 2020;34(7):1220-1223. https://doi.org/10.1038/s41433-020-0965-2
  25. Zhang X, Chen X, Chen L, Deng C, Zou X, Liu W, Yu H, Chen B, Sun X. The evidence of SARS-CoV-2 infection on ocular surface. Ocul Surf. 2020; 18(3):360-362.  https://doi.org/10.1016/j.jtos.2020.03.010
  26. Bostanci Ceran B, Ozates S. Ocular manifestations of coronavirus disease 2019. Graefes Arch Clin Exp Ophthalmol. 2020;258(9):1959-1963. https://doi.org/10.1007/s00417-020-04777-7
  27. Colavita F, Lapa D, Carletti F, Lalle E, Bordi L, Marsella P, Nicastri E, Bevilacqua N, Giancola ML, Corpolongo A, Ippolito G, Capobianchi MR, Castilletti C. SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection. Ann Intern Med. 2020; 173(3):242-243.  https://doi.org/10.7326/M20-1176
  28. Maychuk DYu, Atlas SN, Loshkareva AO. Ocular manifestations of COVID-19 coronavirus infection (clinical observation). Vestnik oftal’mologii. 2020;136(4):118-123 (In Russ.). https://doi.org/10.17116/oftalma2020136041118
  29. Alonso RS, Alonso FOM, Fernandes BF, Ecard VO, Ventura MP. COVID-19-related ocular hypertension secondary to anterior uveitis as part of a multisystemic inflammatory syndrome. J Glaucoma. 2021;30(5):256-258.  https://doi.org/10.1097/IJG.0000000000001835
  30. Bettach E, Zadok D, Weill Y, Brosh K, Hanhart J. Bilateral anterior uveitis as a part of a multisystem inflammatory syndrome secondary to COVID-19 infection. J Med Virol. 2021;93(1):139-140.  https://doi.org/10.1002/jmv.26229
  31. Mazzotta C, Giancipoli E. Anterior acute uveitis report in a SARS-CoV-2 patient managed with adjunctive topical antiseptic prophylaxis preventing 2019-nCoV spread through the ocular surface route. Int Med Case Rep J. 2020;13:513-520.  https://doi.org/10.2147/IMCRJ.S260252
  32. Öztürk C, Yüce Sezen A, Savaş Şen Z, Özdem S. Bilateral acute anterior uveitis and corneal punctate epitheliopathy in children diagnosed with multisystem inflammatory syndrome secondary to COVID-19. Ocul Immunol Inflamm. 2021;29(4):700-704. Epub 2021 Apr 15.  https://doi.org/10.1080/09273948.2021.1909070
  33. Guo D, Xia J, Wang Y, Zhang X, Shen Y, Tong JP. Relapsing viral keratoconjunctivitis in COVID-19: a case report. Virol J. 2020;17(1):97.  https://doi.org/10.1186/s12985-020-01370-6
  34. Cheema M, Aghazadeh H, Nazarali S, Ting A, Hodges J, McFarlane A, Kanji JN, Zelyas N, Damji KF, Solarte C. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can J Ophthalmol. 2020;55(4):125-129.  https://doi.org/10.1016/j.jcjo.2020.03.003
  35. Navel V, Chiambaretta F, Dutheil F. Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2. Am J Ophthalmol Case Rep. 2020; 19:100735. https://doi.org/10.1016/j.ajoc.2020.100735
  36. Hutama SA, Alkaff FF, Intan RE, Maharani CD, Indriaswati L, Zuhria I. Recurrent keratoconjunctivitis as the sole manifestation of COVID-19 infection: A case report. Eur J Ophthalmol. 2021:11206721211006583. https://doi.org/10.1177/11206721211006583
  37. Kurysheva NI. COVID-19 i porazhenie organa zreniya [COVID-19 and damage to the organ of vision]. M.: Largo; 2021. (In Russ.).
  38. Lin C, Ye R, Xia YL. A meta-analysis to evaluate the effectiveness of real-time PCR for diagnosing novel coronavirus infections. Genet Mol Res. 2015; 14(4):15634-15641. https://doi.org/10.4238/2015
  39. Burgos-Blasco B, Güemes-Villahoz N, Santiago JL, Fernandez-Vigo JI, Espino-Paisán L, Sarriá B, García-Feijoo J, Martinez-de-la-Casa JM. Hypercytokinemia in COVID-19: Tear cytokine profile in hospitalized COVID-19 patients. Exp Eye Res. 2020;200:108253. https://doi.org/10.1016/j.exer.2020.108253
  40. Chi Y, Ge Y, Wu B, Zhang W, Wu T, Wen T, Liu J, Guo X, Huang C, Jiao Y, Zhu F, Zhu B, Cui L. Serum cytokine and chemokine profile in relation to the severity of coronavirus disease 2019 in China. J Infect Dis. 2020; 222(5):746-754.  https://doi.org/10.1093/infdis/jiaa363
  41. Grifoni E, Valoriani A, Cei F, Lamanna R, Gelli AMG, Ciambotti B, Vannucchi V, Moroni F, Pelagatti L, Tarquini R, Landini G, Vanni S, Masotti L. Interleukin-6 as prognosticator in patients with COVID-19. J Infect. 2020;81(3):452-482.  https://doi.org/10.1016/j.jinf.2020.06.008
  42. Soy M, Keser G, Atagündüz P, Tabak F, Atagündüz I, Kayhan S. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Clin Rheumatol. 2020;39(7):2085-2094. https://doi.org/10.1007/s10067-020-05190-5
  43. Majtanova N, Kriskova P, Keri P, Fellner Z, Majtan J, Kolar P. Herpes simplex keratitis in patients with SARS-CoV-2 infection: A Series of Five Cases. Medicina (Kaunas). 2021;57(5):412.  https://doi.org/10.3390/medicina57050412
  44. Roberts HW, Akram H, Myerscough J. Negative polymerase chain reaction for SARS-CoV-2 in aqueous sample of patient with confirmed SARS-CoV-2 and recurrence of herpetic stromal keratitis. J Cataract Refract Surg. 2020; 46(12):61-63.  https://doi.org/10.1097/j.jcrs.0000000000000462
  45. Xu R, Zhou Y, Cai L, Wang L, Han J, Yang X, Chen J, Chen J, Ma C, Shen L. Co-reactivation of the human herpesvirus alpha subfamily (herpes simplex virus-1 and varicella zoster virus) in a critically ill patient with COVID-19. Br J Dermatol. 2020;183(6):1145-1147. https://doi.org/10.1111/bjd.19484
  46. Das AV, Narayanan R. Demographics and clinical presentation of patients with ocular disorders during the COVID-19 lockdown in India: A report. Indian J Ophthalmol. 2020;68(7):1393-1399. https://doi.org/10.4103/ijo.IJO_1171_20
  47. Agarwal R, Sharma N, Patil A, Thakur H, Saxena R, Kumar A. Impact of COVID-19 pandemic, national lockdown, and unlocking on an apex tertiary care ophthalmic institute. Indian J Ophthalmol. 2020;68(11):2391-2395. https://doi.org/10.4103/ijo.IJO_2366_20
  48. Rathi VM, Das AV, Khanna RC. Impact of COVID-19-related lockdown-I on a network of rural eye centres in Southern India. Indian J Ophthalmol. 2020;68(11):2396-2398. https://doi.org/10.4103/ijo.IJO_2303_20
  49. Vserossiyskaya nauchno-prakticheskaya onlayn-konferentsiya «Gribkovyye porazheniya glaz» [All-Russian scientific and practical online conference «Fungal eye lesions»]. 28.05.21. Accessed Jun 14, 2021 (In Russ.). https://youtu.be/jC46z1yqvQo
  50. Grixti A, Sadri M, Datta AV. Uncommon ophthalmologic disorders in intensive care unit patients. J Crit Care. 2012;27(6):9-22.  https://doi.org/10.1016/j.jcrc.2012.07.013
  51. Rosenberg JB, Eisen LA. Eye care in the intensive care unit: narrative review and meta-analysis. Crit Care Med. 2008;36(12):3151-3155. https://doi.org/10.1097/CCM.0b013e31818f0ee7
  52. World Health Organisation (WHO). Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Published 2020. Accessed Jun 14, 2021. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected
  53. Sanghi P, Malik M, Hossain IT, Manzouri B. Ocular Complications in the Prone Position in the Critical Care Setting: The COVID-19 Pandemic. J Intensive Care Med. 2021;36(3):361-372.  https://doi.org/10.1177/0885066620959031
  54. Kousha O, Kousha Z, Paddle J. Exposure keratopathy: Incidence, risk factors and impact of protocolised care on exposure keratopathy in critically ill adults. J Crit Care. 2018;44:413-418.  https://doi.org/10.1016/j.jcrc.2017.11.031
  55. Germano EM, Mello MJ, Sena DF, Correia JB, Amorim MM. Incidence and risk factors of corneal epithelial defects in mechanically ventilated children. Crit Care Med. 2009;37(3):1097-1100. https://doi.org/10.1097/CCM.0b013e318196227d
  56. Hartford JB, Bian Y, Mathews PM, De Rojas J, Garg A, Rasool N, Schroder SK, Trief D. Prevalence and Risk Factors of Exposure Keratopathy Across Different Intensive Care Units. Cornea. 2019;38(9):1124-1130. https://doi.org/10.1097/ICO.0000000000001961
  57. Mela EK, Drimtzias EG, Christofidou MK, Filos KS, Anastassiou ED, Gartaganis SP. Ocular surface bacterial colonisation in sedated intensive care unit patients. Anaesth Intensive Care. 2010;38(1):190-193.  https://doi.org/10.1177/0310057X1003800129
  58. Kasparova EvgA. Purulent corneal ulcers: etiology, pathogenesis, classification. Vestnik oftal’mologii. 2015;131(5):87-97 (In Russ.). https://doi.org/10.17116/oftalma2015131587-97
  59. Kasparova EvgA, Kasparov AA, Zajcev AV, Kasparova EA, Shucyun’ Van. Advanced bilateral pseudomonas aeruginosa scleroceratitis in a patient in a coma (clinical case). Vestnik oftal’mologii. 2017;133(4):68-73.  https://doi.org/10.17116/oftalma2017133468-73
  60. Segal KL, Fleischut PM, Kim C, Levine B, Faggiani SL, Banerjee S, Gadalla F, Lelli GJ Jr. Evaluation and treatment of perioperative corneal abrasions. J Ophthalmol. 2014;2014:901901. https://doi.org/10.1155/2014/901901
  61. Lachkar Y, Bouassida W. Drug-induced acute angle closure glaucoma. Curr Opin Ophthalmol. 2007;18(2):129-133.  https://doi.org/10.1097/ICU.0b013e32808738d5
  62. Stewart RJ, Landy DC, Lee MJ. Unilateral Acute Angle-Closure Glaucoma After Lumbar Spine Surgery: A case report and systematic review of the literature. Spine (Phila Pa 1976). 2016;41(5):297-299.  https://doi.org/10.1097/BRS.0000000000001224
  63. Bayyoud T, Iftner T, Bartz-Schmidt KU, Rohrbach JM, Ueffing M, Schindler M, Thaler S. First results of investigations of SARS-CoV-2 RNA in human corneal tissue. Ophthalmologe. 2021;118(suppl 1):78-80.  https://doi.org/10.1007/s00347-020-01254-8
  64. Bayyoud T, Iftner A, Iftner T, Bartz-Schmidt KU, Rohrbach JM, Ueffing M, Schindler M, Thaler S. Absence of severe acute respiratory Syndrome-Coronavirus-2 RNA in human corneal Tissues. Cornea. 2021;40(3):342-347.  https://doi.org/10.1097/ICO.0000000000002479
  65. Casagrande M, Fitzek A, Spitzer MS, Püschel K, Glatzel M, Krasemann S, Nörz D, Lütgehetmann M, Pfefferle S, Schultheiss M. Presence of SARS-CoV-2 RNA in the cornea of viremic patients with COVID-19. JAMA Ophthalmol. 2021;139(4):383-388.  https://doi.org/10.1001/jamaophthalmol.2020.6339

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register


We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.